ALB and hepatitis A virus infection: Following decades of demonstrated safety by pasteurised albumin, early efforts focussed on enhancing the safety of Factor VIII concentrate from hepatitis transmission using this method, with the additional feature of adding excipients to protect factor VIII from inactivation [48].